ACIU Wutah pendapatan triwulanan AC Immune

Logo korporat perusahaan AC Immune (ACIU)

Geopolitical tensions and sanctions are limiting the export of AC Immune (ACIU) neuro-drugs, narrowing its target markets. Reviewing the quarterly revenue changes on GURU.Markets, it is evident that 239.10 determines the current status of the parameter. This is based on confidence in scientific management and partner co-financing, as well as low demand elasticity driven by the unique Morphomer platform for combating Alzheimer's disease.

ACIU (AC Immune S.A.) riwayat Wutah dodolan triwulanan saka 04.07.2022 nganti 20.11.2026

Ringkesan rincian data analitis AC Immune S.A. (ACIU)

- rega saham lan target rega konsensus:
Pambiji fundamental:AC Immune S.A. (ACIU)
Barang unggulan AC Immune SA

For the pharmaceutical business of AC Immune (ACIU), the quarterly revenue trend serves as an indicator of commercial resilience in the development of antibodies against neurodegenerative diseases. This metric measures sales growth rates, assessing cash flow momentum and the company's ability to scale therapy for chronic patients. The calculation is based on a comparison of current quarterly income with the same period last year to neutralize seasonality. Stable growth confirms the effectiveness of patent protection and reduces the risk of asset impairment.

Pesaing utama

BIIB - Wutah pendapatan kuartal marang kuartal|NBIX (Neurocrine Biosciences) - Wutah dodolan kuartal marang kuartal|RGC: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Axsome (AXSM)|Wutah pendapatan kuartal marang kuartal ACADIA Pharmaceuticals Inc|Wutah dodolan triwulanan Xenon Pharmaceuticals Inc (XENE)|Wutah pendapatan triwulanan VKTX|Wutah pendapatan triwulanan supernus.com (SUPN)|Wutah pendapatan kuartal marang kuartal Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Dinamika pendapatan kuartal marang kuartal|Harmony Corp - Wutah pendapatan triwulanan|BHVN: Wutah pendapatan kuartal marang kuartal|AMLX: Wutah pendapatan triwulanan|TRVI: Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Praxis Medicines|Tingkat wutah pendapatan sajrone kuartal Anavex AVXL|Wutah pendapatan kuartal marang kuartal CeriBell Corp (CBLL)|Owah-owahan dodolan kuartal marang kuartal PRTA|Wutah pendapatan triwulanan ALEC (Alector)|Annexon (ANNX) - Tingkat wutah pendapatan sajrone kuartal|OMER - Wutah pendapatan kuartal marang kuartal|NGNE (Neurogene) - Wutah dodolan kuartal marang kuartal|Voyager Corp (VYGR) - Wutah pendapatan kuartal marang kuartal|NMRA - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Scilex|TVGN (Tevogen Bio) - Owah-owahan dodolan kuartal marang kuartal|Wutah dodolan triwulanan ACOG (alphacognition.com)|Tingkat wutah dodolan sajrone kuartal Cognition Therapeutics, Inc.|Wutah pendapatan triwulanan IKT (Inhibikase Pharma)|Wutah pendapatan triwulanan Cassava Sciences, Inc. SAVA|ASRT - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Wutah pendapatan kuartal marang kuartal|OVID - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Acumen Pharmaceuticals, Inc|Wutah pendapatan kuartal marang kuartal CRVO|Wutah pendapatan triwulanan ATHE|Clene - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PEPG (pepgen.com)|JUNS: Wutah dodolan kuartal marang kuartal|RLMD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Firefly Neuroscience (AIFF)|Wutah dodolan triwulanan KLTO|NRSN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Reviva Pharmaceuticals Holdings (RVPH)|Wutah dodolan triwulanan MetaVia, Inc. MTVA|Wutah pendapatan kuartal marang kuartal NeurAxis NRXS|HSDT: Wutah dodolan kuartal marang kuartal|passagebio.com - Wutah pendapatan triwulanan|NEUP - Wutah pendapatan triwulanan|Minerva Neurosciences Corp (NERV) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ALZN (Alzamend Neuro)|Wutah pendapatan kuartal marang kuartal Cyclerion Therapeutics Inc. (CYCN)|Wutah pendapatan triwulanan Protagenic Therapeutics, Inc. (PTIX)|Wutah pendapatan triwulanan KTTA (Pasithea Therapeutics Corp)|CRGT - Wutah dodolan triwulanan|ATXI - Wutah pendapatan kuartal marang kuartal|BCLI: Wutah pendapatan kuartal marang kuartal|Cara Therapeutics (CARA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Chromocell Therapeutics Corp (CHRO)|Wutah dodolan triwulanan ELYM|Tingkat wutah pendapatan sajrone kuartal intracellulartherapies.com ITCI|Wutah pendapatan kuartal marang kuartal Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal NKGen NKGN|Wutah pendapatan triwulanan NeuroBo Pharmaceuticals Inc NRBO|SAGE: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Synaptogenix, Inc SNPX|TRVN: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Vigil Neuroscience (VIGL)|Wutah pendapatan kuartal marang kuartal Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal